Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031)
Authors
Parker, C. C.Clarke, N.
Cook, A.
Catton, C.
Cross, W. R.
Kynaston, H.
Logue, John P
Petersen, P. M.
Neville, P.
Persad, R.
Payne, H.
Saad, F.
Stirling, A.
Parulekar, W. R.
Parmar, M. K.
Sydes, M. R.
Affiliation
Department Of Uro-oncology, The Royal Marsden Hospital (Sutton) - NHS Foundation Trust, SM2 5PT - Sutton/GBIssue Date
2022
Metadata
Show full item recordCitation
Parker CC, Clarke N, Cook A, Catton C, Cross WR, Kynaston H, et al. Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031). Annals of Oncology. 2022 Sep;33(7):S1427-S. PubMed PMID: WOS:000866211602474.Journal
Annals of OncologyDOI
10.1016/annonc/annonc1089Additional Links
https://dx.doi.org/10.1016/annonc/annonc1089Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/annonc/annonc1089